Business Coach
9562
Artra Group
6029
Daiwa Cycle
5888
Liberta
4935
D. Western Therapeutics Institute
4576
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | |
---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | |||||||
Cash from operating activities | -19.39%-2.56B | -57.82%-2.14B | -239.53%-1.36B | -131.76%-399.88M | 66.48%-172.54M | -5.53%-514.76M | -487.76M |
Net profit before non-cash adjustment | 1.95%-2.53B | -111.34%-2.58B | -628.14%-1.22B | 228.84%231.43M | 60.82%-179.63M | 6.14%-458.51M | ---488.52M |
Total adjustment of non-cash items | 40.15%1.14B | 876.26%812.59M | 2,398.80%83.24M | -94.31%3.33M | 136.31%58.52M | 12,735.20%24.77M | ---196K |
-Depreciation and amortization | 61.41%118.43M | 11,101.83%73.37M | -97.59%655K | 26.35%27.14M | 66.83%21.48M | 104.80%12.88M | --6.29M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | --8.51M | ---- | ---- | ---- | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | --1.47M |
-Disposal profit | 5.59%431.71M | --408.87M | --0 | ---- | -39.15%2.65M | 107.44%4.35M | --2.1M |
-Other non-cash items | 78.20%588.7M | 345.98%330.35M | 411.10%74.07M | -169.23%-23.81M | 356.21%34.39M | 175.04%7.54M | ---10.05M |
Changes in working capital | -212.80%-1.16B | -70.19%-372.17M | 65.54%-218.68M | -1,133.76%-634.64M | 36.51%-51.44M | -8,628.11%-81.02M | --950K |
-Change in receivables | 178.18%251.26M | -214.64%-321.4M | 150.13%280.36M | -201.38%-559.29M | -694.78%-185.57M | -190.53%-23.35M | --25.79M |
-Change in inventory | -65.15%-1.21B | -1,056.22%-732.42M | -15.25%-63.35M | -396.70%-54.97M | 123.17%18.53M | -170.04%-79.95M | ---29.61M |
-Change in prepaid assets | 159.55%266.89M | 132.79%102.83M | ---313.57M | ---- | ---- | ---- | ---- |
-Change in payables | -171.30%-489.42M | 491.38%686.38M | -648.85%-175.37M | 50.54%31.95M | 150.67%21.23M | -150.63%-41.89M | --82.74M |
-Change in accrued expense | ---- | ---- | ---- | ---- | ---- | ---- | ---17.36M |
-Provision for loans, leases and other losses | ---- | ---- | ---- | 162.12%14.34M | 785.44%5.47M | --618K | ---- |
-Changes in other current assets | 115.53%16.7M | -302.00%-107.56M | 179.86%53.25M | -174.99%-66.68M | 39.91%88.91M | 204.84%63.55M | ---60.62M |
Dividends paid (cash flow from operating activities) | |||||||
Dividends received (cash flow from operating activities) | |||||||
Interest paid (cash flow from operating activities) | -314.54%-9.44M | -2.28M | 0 | -2.36M | 0 | ||
Interest received (cash flow from operating activities) | -39.55%321K | 103.45%531K | -17.41%261K | 1,273.91%316K | 283.33%23K | -88.89%6K | 54K |
Tax refund paid | -34.76%-5.09M | -132.60%-3.78M | 412.32%11.59M | -94.75%-3.71M | -556.90%-1.91M | -504.17%-290K | -48K |
Other operating cash inflow (outflow) | 1K | 0 | 100.02%1K | -86.95%-4.72M | -2.52M | 0 | 2K |
Operating cash flow | -19.74%-2.57B | -59.62%-2.15B | -229.88%-1.35B | -130.58%-407.99M | 65.80%-176.94M | -6.08%-517.4M | ---487.75M |
Investing cash flow | |||||||
Net PPE purchase and sale | 51.41%-40.38M | -812.01%-83.09M | 46.09%-9.11M | 41.88%-16.9M | -50.01%-29.08M | 22.83%-19.39M | ---25.12M |
Net intangibles purchase and sale | 57.41%-54.13M | -285.12%-127.09M | 5.30%-33M | -223.94%-34.85M | 13.38%-10.76M | 2.77%-12.42M | ---12.77M |
Net investment product transactions | --0 | 84.70%-60.96M | -30.61%-398.58M | ---305.18M | ---- | --140.01M | ---- |
Advance cash and loans provided to other parties | ---- | ---- | ---284.75M | ---- | ---- | ---- | ---- |
Net changes in other investments | 198.36%60K | 99.77%-61K | -104.30%-26.43M | 29.02%-12.94M | -7,462.24%-18.23M | -100.04%-241K | --606.08M |
Investing cash flow | 65.18%-94.44M | 63.93%-271.21M | -103.29%-751.88M | -537.00%-369.86M | -153.78%-58.06M | -81.00%107.97M | --568.19M |
Financing cash flow | |||||||
Net issuance payments of debt | -110.50%-105M | --1B | --0 | ---- | -200.00%-198M | --198M | ---- |
Net common stock issuance | 12,514.53%1.64B | -99.56%12.98M | 3,264.64%2.96B | -96.90%88.11M | 34.16%2.84B | --2.12B | ---- |
Issuance fees | ---- | ---- | ---- | ---- | ---14.55M | ---- | ---- |
Cash dividends for minorities | ---1.1M | --0 | ---- | ---- | ---- | ---- | ---- |
Net other fund-raising expenses | 137,368.60%1.28B | -7.09%930K | 524.15%1M | -23,700.00%-236K | -99.96%1K | --2.25M | ---- |
Financing cash flow | 177.12%2.81B | -65.81%1.01B | 3,274.81%2.97B | -96.66%87.87M | 13.42%2.63B | --2.32B | --0 |
Net cash flow | |||||||
Beginning cash position | -50.86%1.36B | 45.90%2.76B | -57.64%1.89B | 115.84%4.47B | 1,208.77%2.07B | 103.59%158.08M | --77.65M |
Current changes in cash | 110.17%142.99M | -261.96%-1.41B | 225.77%867.79M | -128.79%-689.97M | 25.43%2.4B | 2,275.62%1.91B | --80.44M |
Effect of exchange rate changes | -82.25%318K | 311.01%1.79M | --436K | ---- | ---- | ---- | ---- |
Cash adjustments other than cash changes | ---- | ---- | ---- | 0.00%-1K | -200.00%-1K | --1K | ---- |
End cash Position | 10.57%1.5B | -50.86%1.36B | -26.90%2.76B | -15.45%3.78B | 115.84%4.47B | 1,208.77%2.07B | --158.08M |
Free cash flow | -13.08%-2.67B | -69.92%-2.36B | -201.91%-1.39B | -112.07%-459.73M | 60.53%-216.78M | -4.48%-549.21M | ---525.65M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |